• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The molecular basis of isoniazid resistance in Mycobacterium tuberculosis.

作者信息

Heym B, Saint-Joanis B, Cole S T

机构信息

Service de Microbiologie, Hôpital Ambroise-Paré, Boulogne, France.

出版信息

Tuber Lung Dis. 1999;79(4):267-71. doi: 10.1054/tuld.1998.0208.

DOI:10.1054/tuld.1998.0208
PMID:10692996
Abstract
摘要

相似文献

1
The molecular basis of isoniazid resistance in Mycobacterium tuberculosis.结核分枝杆菌中异烟肼耐药性的分子基础。
Tuber Lung Dis. 1999;79(4):267-71. doi: 10.1054/tuld.1998.0208.
2
Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA.结核分枝杆菌异烟肼耐药性的分子特征：inhA基因新突变的鉴定
Antimicrob Agents Chemother. 2006 Mar;50(3):1075-8. doi: 10.1128/AAC.50.3.1075-1078.2006.
3
The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis.结核分枝杆菌的过氧化氢酶-过氧化物酶基因与异烟肼耐药性
Nature. 1992 Aug 13;358(6387):591-3. doi: 10.1038/358591a0.
4
[A simple enzyme test for proving the resistance to isoniazid of Mycobacterium tuberculosis strains].[一种用于证明结核分枝杆菌菌株对异烟肼耐药性的简单酶试验]
Pneumologia. 2005 Apr-Jun;54(2):58-61.
5
Molecular characterisation of isoniazid-resistant Mycobacterium tuberculosis isolated from new cases in Lagunes region (Côte d'Ivoire).从拉古内斯地区（科特迪瓦）新病例中分离出的耐异烟肼结核分枝杆菌的分子特征分析
Int J Antimicrob Agents. 2008 May;31(5):498-500. doi: 10.1016/j.ijantimicag.2008.01.008. Epub 2008 Mar 4.
6
Reduced affinity for Isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance.结核分枝杆菌KatG的S315T突变体对异烟肼的亲和力降低是抗生素耐药性的关键因素。
J Biol Chem. 2003 Apr 25;278(17):14769-75. doi: 10.1074/jbc.M300326200. Epub 2003 Feb 13.
7
Resonance Raman spectroscopy of Compound II and its decay in Mycobacterium tuberculosis catalase-peroxidase KatG and its isoniazid resistant mutant S315T.结核分枝杆菌过氧化氢酶-过氧化物酶KatG及其异烟肼耐药突变体S315T中化合物II的共振拉曼光谱及其衰变
J Inorg Biochem. 2005 Jun;99(6):1401-6. doi: 10.1016/j.jinorgbio.2005.03.016.
8
Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations.用katG进行转化可恢复对一系列药物浓度耐药的结核分枝杆菌分离株的异烟肼敏感性。
Mol Microbiol. 1993 May;8(3):521-4. doi: 10.1111/j.1365-2958.1993.tb01596.x.
9
KatG sequence deletion is not the major cause of isoniazid resistance in Japanese and Yemeni Mycobacterium tuberculosis isolates.KatG序列缺失不是日本和也门结核分枝杆菌分离株对异烟肼耐药的主要原因。
Mol Cell Probes. 1995 Dec;9(6):433-9. doi: 10.1006/mcpr.1995.0066.
10
[KatG Ser3 15Thr mutation as the main reason of isoniazid resistance in Mycobacterium tuberculosis isolated in the Novosibirsk and Kemerovo Regions].[KatG基因Ser315Thr突变作为新西伯利亚和克麦罗沃地区分离出的结核分枝杆菌对异烟肼耐药的主要原因]
Mol Gen Mikrobiol Virusol. 2004(3):8-11.

引用本文的文献

1
Mutations and insights into the molecular mechanisms of resistance of Mycobacterium tuberculosis to first-line.结核分枝杆菌对一线药物耐药的分子机制的突变与见解。
Genet Mol Biol. 2023 Jan 23;46(1 Suppl 2):e20220261. doi: 10.1590/1678-4685-GMB-2022-0261. eCollection 2023.
2
Molecular Analysis of Encoding Catalase-Peroxidase from Clinical Isolate of Isoniazid-Resistant Mycobacterium tuberculosis.耐异烟肼结核分枝杆菌临床分离株编码过氧化氢酶-过氧化物酶的分子分析
J Med Life. 2018 Apr-Jun;11(2):160-167.
3
Genotyping of Mycobacterium tuberculosis using whole genome sequencing.
利用全基因组测序对结核分枝杆菌进行基因分型。
Folia Microbiol (Praha). 2018 Sep;63(5):537-545. doi: 10.1007/s12223-018-0599-y. Epub 2018 Mar 17.
4
Anti-mycobacterium tuberculosis activity of polyherbal medicines used for the treatment of tuberculosis in Eastern Cape, South Africa.南非东开普用于治疗结核病的多草药药物的抗结核分枝杆菌活性
Afr Health Sci. 2017 Sep;17(3):780-789. doi: 10.4314/ahs.v17i3.21.
5
First experience with using simple polymerase chain reaction-based methods as an alternative to phenotypic drug susceptibility testing for Myobacterium tuberculosis in Iraq.在伊拉克，首次尝试使用基于简单聚合酶链反应的方法替代结核分枝杆菌的表型药敏试验。
Int J Appl Basic Med Res. 2013 Jul;3(2):98-105. doi: 10.4103/2229-516X.117069.
6
Challenges in the development of drugs for the treatment of tuberculosis.抗结核药物研发面临的挑战。
Braz J Infect Dis. 2013 Jan-Feb;17(1):74-81. doi: 10.1016/j.bjid.2012.10.009. Epub 2013 Jan 1.
7
A balancing act: efflux/influx in mycobacterial drug resistance.一种平衡行为：分枝杆菌耐药中的外排/内流
Antimicrob Agents Chemother. 2009 Aug;53(8):3181-9. doi: 10.1128/AAC.01577-08. Epub 2009 May 18.
8
Use of a mycobacteriophage-based assay for rapid assessment of susceptibilities of Mycobacterium tuberculosis isolates to isoniazid and influence of resistance level on assay performance.使用基于分枝杆菌噬菌体的检测方法快速评估结核分枝杆菌分离株对异烟肼的敏感性以及耐药水平对检测性能的影响。
J Clin Microbiol. 2006 Jan;44(1):201-5. doi: 10.1128/JCM.44.1.201-205.2006.
9
Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil.巴西获得的耐异烟肼结核分枝杆菌分离株中突变的筛选与鉴定
Antimicrob Agents Chemother. 2004 Sep;48(9):3373-81. doi: 10.1128/AAC.48.9.3373-3381.2004.
10
Therapeutic drug monitoring in the treatment of tuberculosis.结核病治疗中的治疗药物监测
Drugs. 2002;62(15):2169-83. doi: 10.2165/00003495-200262150-00001.